Short review on domperidone tablet

Shaveta Sharma; Diksha Chandel; Puneet Sudan; Upendra K. Jain

Authors

Shaveta Sharma Chandigarh College of Pharmacy, Landran, Mohali, Punjab
Diksha Chandel Chandigarh College of Pharmacy, Landran, Mohali, Punjab
Puneet Sudan Chandigarh College of Pharmacy, Landran, Mohali, Punjab
Upendra K. Jain Chandigarh College of Pharmacy, Landran, Mohali, Punjab

Keywords:

ODT, Domperidone tablets, Improved Bioavailability

Abstract

Oral route is presently the gold standard in the pharmaceutical industry where it is regarded as the safest, most economical and most convenient method of drug delivery resulting in highest patient compliance. Pediatric and geriatric patients find it difficult to swallow solid dosage forms like tablets. Mouth dissolving tablet that dissolve or disintegrate rapidly in oral cavity result in solution, is an ultimate remedy for this problem in addition they give pleasing mouth feeling. ODT has advantages such as patient compliance, quick onset of action, improved bioavailability. Domperidone tablet (ODT) gives relief from nausea, vomiting. This review gives us all information about pharmacokinetic, pharmacodynamic, uses, precautions, side effects of domperidone tablets

Downloads

Download data is not yet available.

References

Reddymasu, Savio C.; Soykan, Irfan; McCallum, Richard W. (2007). "Domperidone: Review of Pharmacology and Clinical Applications in Gastroenterology". The American Journal of Gastroenterology. 102 (9) pp 2036-2045

SavioC; Reddymasu MD, Irfan Soykan MD and Richard W McCallum MD. The American Journal of Gastroenterology (2007) 102, pp2036–2045

Girault JA, Greengard P (2004). "The neurobiology of dopamine signaling". Arch. Neurol. 61 (5): pp641–4.

Asztalos EV, Campbell-Yeo M, daSilva OP, Kiss A, Knoppert DC, Ito S (2012). "Enhancing breast milk production with Domperidone in mothers of preterm neonates .”da Silva OP, Knoppert DC (September 2004). "Domperidone for lactating women". CMAJ. 171 (7): pp725–6.

Fujino T, Kato H, Yamashita S, Aramaki S, Morioka H, Koresawa M, Miyauchi F, Toyoshima H, Torigoe T (1980). "Effects of domperidone on serum prolactin levels in human beings". Endocrinol. Jpn. 27(40).pp521 .

Hofmeyr GJ, Van Iddekinge B, Blott JA (1985). "Domperidone: secretion in breast milk and effect on puerperal prolactin levels". Br J Obstet Gynaecol. 92 (2): pp141-144.

Stan K. Bardal; Jason E. Waechter; Douglas S. Martin (2011). Applied Pharmacology. Elsevier Health Sciences.pp184.

Janssen P, Harris MS, Jones M, Masaoka T, Farré R, Törnblom H, Van Oudenhove L, Simrén M, Tack J (September 2013). "The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis". The American Journal of Gastroenterology. 108 (9): pp1382–91.

Shindler JS, Finnerty GT, Towlson K, Dolan AL, Davies CL, Parkes JD (December 1984). "Domperidone and levodopa in Parkinson's disease". British Journal of Clinical Pharmacology. 18 (6): pp959–62

Swann IL, Thompson EN, Qureshi K (November 1979). "Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting". British Medical Journal. 2 (6199): pp1188.

Coulthard MG, Haycock GB (January 2003). "Distinguishing between salt poisoning and hypernatraemic dehydration in children". BMJ (Clinical Research Ed.). 326 (7381): pp157–60.

Ortiz, Arleen; Cooper, Chad J.; Alvarez, Alicia; Gomez, Yvette; Sarosiek, Irene; McCallum, Richard W. (2015). "Cardiovascular Safety Profile and Clinical Experience With High-Dose Domperidone Therapy for Nausea and Vomiting". The American Journal of the Medical Sciences. 349 (5): pp421–424.

"DRUGS AND COSMETICS (2ND AMENDMENT) RULES, 2006". Department of Health. New Delhi: Ministry of Health and Family Welfare of GOI in The Gazette of India (extraordinary) Part-II, section 3, sub-section (i) vide G.S.R. 160(E), dated 16th March, 2006. 16 March 2006. Archived from the original on 21 February 2007. Retrieved 23 February 2015

Aggarwal Jyoti, Singh Gurpreet, Saini Seema, Rana A C: A novel approach to oral drug delivery. International research journal of pharmacy, 2011; 2(12): pp 69-74.

National Institute of Drug Abuse (2010). Prescription Drugs: Abuse and Addiction. Report Research Series - Accessed: July 21, 2016